An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

Clinical trial NCT07631871 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07631871
Sponsor: Haihua Yuan
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Solid Tumors HER2 Positive Solid Tumor Endometrial Neoplasm Urothelial Carcinoma (UC)Pancreatic Neoplasms Colorectal Neoplasms Head and Neck Neoplasms Cervical Neoplasms Ovarian Neoplasms

Start date: 2026-06-15
Primary completion: 2029-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.